3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
6
Leukemia, Myeloid, Acute
6
Leukemia
4
Carcinoma
3
Hematologic Diseases
2
Small Cell Lung Carcinoma
1
Sarcoma, Myeloid
1
Recurrence
1
Myelodysplastic Syndromes
1
Leukemia, Myelomonocytic, Chronic
1
Carcinoma, Small Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma
1
Acute Disease
1
Interventions
Cyclophosphamide
48
fludarabine phosphate
45
fludarabine
38
Whole-Body Irradiation
38
Mycophenolic Acid
37
Imatinib Mesylate
36
nilotinib
34
Tacrolimus
30
Busulfan
23
Cyclosporine
18
Melphalan
17
Granulocyte Colony-Stimulating Factor
17
Dasatinib
17
thymoglobulin
16
Methotrexate
16
Thiotepa
15
Peripheral Blood Stem Cell Transplantation
15
Antilymphocyte Serum
15
bosutinib
13
Filgrastim
13
Stem Cell Transplantation
11
sargramostim
8
ponatinib
8
Cytarabine
8
Cyclosporins
8
Cord Blood Stem Cell Transplantation
8
Clofarabine
8
Sirolimus
7
Rituximab
7
plerixafor
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
vosaroxin
×
Clear all
No trials found.